Standing in his lab at Harvard, Professor Sean Eddy stares at vacant workstations. A year ago, this space buzzed with over a dozen researchers. They collaborated over coffee, troubleshooting complex genomic data together. Now, silence fills the air; the essential equipment is gone, a haunting reminder of the lab’s former vibrancy.
“These labs shouldn’t be empty like this,” he reflects. “This was once a lively place.”
Eddy, a computational biologist, has dedicated years to unraveling life’s origins. He and his team developed crucial software that aids scientists worldwide in comparing DNA and protein sequences. This work supports countless studies, from cancer research to understanding neurodevelopmental disorders.
Despite his contributions, things took a turn in 2025 when federal funding was cut. Eddy describes the impact as staggering, calling it a “10-year hit to a lab.” He lost almost his entire team. The National Institutes of Health (NIH) even labeled his work as offering “no value,” leading to a deep sense of uncertainty.
Eddy’s journey reflects a broader crisis in U.S. science. Research funding has faced drastic fluctuations, especially after the funding cuts under the Trump administration. Recently, discussions have emerged about restoring funding, but many advocates remain skeptical. Jeremy Berg, a former NIH official, highlights the disconnection between budget numbers and actual funding distributions, noting, “There’s a lot of pain and a lot of science that isn’t going to get done.”
In fact, NIH awarded roughly half as many grants in early 2026 compared to the previous year. Berg argues that a lack of transparency has birthed distrust in the agency’s operations.
Many researchers, like Eddy, are left wondering about their futures. Eddy feels he’s missed the window for recovery. “For someone at my stage of career, this is probably not recoverable,” he admits.
The implications are grave, not just for scientists but for the advancements that could benefit society. Rachael Sirianni, a cancer researcher, echoes this sentiment as she waits for funding on research critical to treating childhood cancers. “It’s a loss of investment and momentum for families fighting these conditions,” she states.
The situation has sparked frustration among scientists and advocates who emphasize that every moment counts in their work. As delays continue with funding and agency communication, many fear a generation of research could be lost. The need for a reliable system is more urgent than ever.
Overall, the state of funding for scientific research illustrates a larger concern not just for Eddy and Sirianni, but for all those who rely on advancements born from these labs. The potential for breakthroughs in various fields hangs in the balance as researchers navigate this turbulent landscape.
For more details on the NIH funding situation, you can read about it in reports from trusted sources like the Association of American Universities.
